How San Diego rose to a biotech hub

The growth is unmistakable: The San Diego biotech industry now routinely ranks third in the nation, behind Boston and the Bay Area. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by     Biotech is practically in San Diego’s DNA. Here’s how it got there — and how it might evolve By Jonathan Wosen Crystal Milner/STAT In San Diego's biotech industry, the workforce, investment dollars, and company creation are surging at record levels. The region is now grappling with if and how it can sustain this staggering growth. Read More Sponsor content by cvs health  Standing with America’s pharmacists Our pharmacies have been on the frontlines and played a key role in our public health system for decades, and the scale of the pandemic response from our pharmacists and their teams was made possible by temporary federal authority. Now it’s time to permanently advance and codify those policies in Congress. Congress: Our pharmacists and their teams stood ready to support us during the pandemic. Let’s now support them in their continued mission to deliver increased access to care. More great reads from STAT this week Exclusive: CVS whistleblower details how patients were charged higher drug prices By Ed Silverman Many Blue Cross Blue Shield plans aren’t paying taxes — and instead are swimming in refunds By Bob Herman Facebook is receiving sensitive medical information from hospital websites By Todd Feathers, Simon Fondrie-Teitler, Angie Waller, and Surya Mattu — The Markup Girl’s case of lupus leads to new understanding of a perplexing disease By Isabella Cueto Francis Collins on his new life as White House science adviser By Lev Facher Life expectancy for Native Americans has stagnated — even long before Covid By Usha Lee McFarling The FTC says it’s getting tougher on hospital consolidation. Antitrust experts aren’t buying it By Tara Bannow Listen: Diverse clinical trials: Why aren’t we there yet? By Nicholas St. Fleur A CDC study seeks to provide clues to seeming surge of hepatitis cases in kids By Helen Branswell Understanding long Covid will take the lived experiences of long haulers By Zeenia Framroze Saturday, June 18, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser